2020
DOI: 10.1111/imj.15057
|View full text |Cite
|
Sign up to set email alerts
|

Tioguanine as an alternative immunomodulator in inflammatory bowel diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…[13] EEN is also effective in inducing remission, promoting fistula closure and reducing abscess size in patients with fistulising CD. [14,15] Therefore, early introduction of EEN is important for optimising nutrition and inducing remission. We successfully used EEN in 72% of our participants.…”
Section: Discussionmentioning
confidence: 99%
“…[13] EEN is also effective in inducing remission, promoting fistula closure and reducing abscess size in patients with fistulising CD. [14,15] Therefore, early introduction of EEN is important for optimising nutrition and inducing remission. We successfully used EEN in 72% of our participants.…”
Section: Discussionmentioning
confidence: 99%
“…6 AEs including nodular regenerative hyperplasia are extremely rare with the doses used for IBD. [6][7][8][9] Additionally, thioguanine produces more predictable 6-TGN metabolites and may have a quicker onset of action and greater clinical efficacy than conventional thiopurines. 9 An interesting addition to the study would have been a third arm using thioguanine, which would mechanistically achieve similar effects to thiopurine/allopurinol co-therapy and would have been simpler to implement.…”
Section: Letter: Thioguanine An Underutilised Option In Inflammatory ...mentioning
confidence: 99%